Adrenal Insufficiency and Glucocorticoid Use During the COVID-19 Pandemic

The coronavirus disease 2019 (COVID-19) is an emerging pandemic challenge. Acute respiratory distress syndrome (ARDS) in COVID-19 is characterized by a severe cytokine storm. Patients undergoing glucocorticoid (GC) replacement therapy for adrenal insufficiency (AI) represent a highly vulnerable grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Almeida, Madson Q., Mendonca, Berenice B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculdade de Medicina / USP 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279638/
https://www.ncbi.nlm.nih.gov/pubmed/32555949
http://dx.doi.org/10.6061/clinics/2020/e2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279638/
https://www.ncbi.nlm.nih.gov/pubmed/32555949
http://dx.doi.org/10.6061/clinics/2020/e2022

Ejemplares similares